SCHEMBL21389154

SCHEMBL21389154

O=C(O)CSCC(=O)NCCN1C(=O)C2=C(CCCC2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.40
▸ FABP4 P15090 2/20 0.38
▸ FABP3 P05413 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ USP2 O75604 1/20 0.34
▸ MITF O75030 1/20 0.33
▸ KLF5 Q13887 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26746416 0.88 ALDH1A1 (0.38) GAAALDH1A1KDM4EHPGDNPC1
SCHEMBL21389314 0.83 CYP1A2 (0.37) GAAALDH1A1KDM4EHPGDNPC1
SCHEMBL24796302 0.83 HPGD (0.44) GAAALDH1A1HPGDNPC1POLB
SCHEMBL21389091 0.83 KMT2A (0.40) GAAFABP4FABP3ALDH1A1HPGD
SCHEMBL21389103 0.82 KMT2A (0.44) GAAFABP4FABP3ALDH1A1HPGD
SCHEMBL21384318 0.81 ALDH1A1 (0.49) GAAFABP4FABP3ALDH1A1KDM4E
SCHEMBL21389183 0.80 ALDH1A1 (0.39) GAAFABP4FABP3ALDH1A1RAB9A
SCHEMBL24795886 0.80 ALDH1A1 (0.39) GAAFABP4FABP3ALDH1A1RAB9A
SCHEMBL21389145 0.80 ALDH1A1 (0.42) GAAFABP4FABP3ALDH1A1RAB9A
SCHEMBL21389394 0.79 GAA (0.38) GAAFABP4FABP3ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
US-11535660-B1 Modulators of G-protein coupled receptors Cannot Therapeutics, Inc. (US) 2022-12-27 — — US disclosed
WO-2019183577-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. (US) 2019-09-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR GAA 1526/4885FABP4 1047/4885FABP3 666/4885
US-11535660-B1 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR GAA 1536/4885FABP4 1018/4885FABP3 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback